Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP368522.RA7BFFGicz0fQ0U0vK6AuohTmkW5Bb_6g1bXeypvEjrXc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP368522.RA7BFFGicz0fQ0U0vK6AuohTmkW5Bb_6g1bXeypvEjrXc130_assertion type Assertion NP368522.RA7BFFGicz0fQ0U0vK6AuohTmkW5Bb_6g1bXeypvEjrXc130_head.
- NP368522.RA7BFFGicz0fQ0U0vK6AuohTmkW5Bb_6g1bXeypvEjrXc130_assertion description "[Thus, MGMT assessment can be useful in predicting response in GBM, but the scarcity of neoplastic cells limits the practicality of MGMT assessment in these tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP368522.RA7BFFGicz0fQ0U0vK6AuohTmkW5Bb_6g1bXeypvEjrXc130_provenance.
- NP368522.RA7BFFGicz0fQ0U0vK6AuohTmkW5Bb_6g1bXeypvEjrXc130_assertion evidence source_evidence_literature NP368522.RA7BFFGicz0fQ0U0vK6AuohTmkW5Bb_6g1bXeypvEjrXc130_provenance.
- NP368522.RA7BFFGicz0fQ0U0vK6AuohTmkW5Bb_6g1bXeypvEjrXc130_assertion SIO_000772 12684420 NP368522.RA7BFFGicz0fQ0U0vK6AuohTmkW5Bb_6g1bXeypvEjrXc130_provenance.
- NP368522.RA7BFFGicz0fQ0U0vK6AuohTmkW5Bb_6g1bXeypvEjrXc130_assertion wasDerivedFrom befree-20140225 NP368522.RA7BFFGicz0fQ0U0vK6AuohTmkW5Bb_6g1bXeypvEjrXc130_provenance.
- NP368522.RA7BFFGicz0fQ0U0vK6AuohTmkW5Bb_6g1bXeypvEjrXc130_assertion wasGeneratedBy ECO_0000203 NP368522.RA7BFFGicz0fQ0U0vK6AuohTmkW5Bb_6g1bXeypvEjrXc130_provenance.